Jinling Pharmaceutical
Overview
Jinling Pharmaceutical Company Limited, together with its subsidiaries, manufactures and sells pharmaceuticals and medical devices in China and internationally. It offers Mailuoning injection and oral solution for the treatment of thromboangiitis and arteriosclerosis obliterans, as well as cerebral and venous thrombosis; Sulifei, a ferrous succinate tablet for the prevention and treatment of iron deficiency anemia; Lentinan injection, an adjuvant therapy for the treatment of malignant tumors; an
Employees5716
Market Cap$3.8B
Revenue$3.2B
Listed OnShenzhen Stock Exchange
Ticker000919
CEOMr. Hai Chen
HeadquartersNanjing